Viewing nowNeumantin Tablet (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

MFDS item code 201901527 · Approved 2019.03.12 · Insurance code 663607660
Treatment of moderate to severe Alzheimer’s disease
This medication is used for the treatment of moderate to severe Alzheimer's disease. Alzheimer's disease is a condition characterized by a gradual decline in memory and cognitive function, and this medication helps to slow the progression of symptoms and improve daily living abilities. Taking the medication regularly as prescribed is effective for managing symptoms according to the patient's condition.
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer’s dementia, and only when a caregiver is able to regularly check that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medication and the patient’s tolerability of treatment should be reassessed regularly. This medication is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. It may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Day 1–7) Administer 5mg once daily for 7 days. Week 2 (Day 8–14) Administer 10mg once daily for 7 days. Week 3 (Day 15–21) Administer 15mg once daily for 7 days. From Week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults: Based on clinical data, the recommended dose for patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of administration, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medication.
This medication should not be used in patients with known allergies to its components. Avoid using in patients with severely impaired liver function or chronic kidney disease. Caution is advised when using this medication in patients with epilepsy, those who have experienced seizures in the past, or those prone to seizures. Combining this medication with other drugs that have similar effects may increase the risk of central nervous system side effects; therefore, it is best to avoid concomitant use. Situations where the acidity (pH) of urine changes may affect the excretion of the drug and should be monitored closely. Patients with uncontrolled heart disease or hypertension should consult with a physician before use. During treatment, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur; if symptoms are severe, notify healthcare professionals. Interactions with other medications may occur, which requires caution, especially when taken alongside antipsychotic medications, muscle relaxants, and anticoagulants. Women who are pregnant or may become pregnant should consider the risks and benefits carefully before using this medication, and breastfeeding should be stopped if using this medication. Use is not recommended for children or adolescents under 18 years of age, as safety and efficacy have not been established. In case of overdose, symptoms such as confusion, drowsiness, dizziness, and vomiting may occur; immediate medical attention should be sought. This medication can affect the central nervous system, so caution is necessary while driving or operating machinery. Keep out of reach of children, and avoid transferring the medication to another container, as this can lead to accidents and degradation of quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. Additionally, it is important to store the medication at room temperature between 1°C and 30°C to maintain its effectiveness.
White rectangular film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.